Sudarshan Pharma Industries Ltd. - Research Center

---

Results

• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

465.56

461.33

357.09

193.35

147.98

Operating profit

22.60

14.69

10.92

7.18

4.61

Interest

9.03

5.40

3.38

3.13

2.57

Gross profit

16.33

10.41

8.01

4.32

2.06

EPS (Rs)

4.72

3.95

7.32

2.80

1.34

Other income

2.75

1.12

0.46

0.27

0.02

Stock adjustment

-7.87

-26.62

-22.91

-6.59

-6.97

Raw material

4.82

0.32

-

-

-

Power and fuel

-

-

-

-

-

Employee expenses

3.50

2.98

2.43

1.62

1.60

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

442.51

469.97

366.65

191.14

148.73

Provisions made

-

-

-

-

-

Depreciation

1.23

0.91

0.87

0.74

0.35

Taxation

3.74

-

-

0.90

0.44

Net profit / loss

11.36

9.50

7.14

2.67

1.28

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

24.07

24.07

9.75

9.55

9.55

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

4.86

3.18

3.06

3.72

3.12

GPM (%)

3.49

2.25

2.24

2.23

1.39

NPM (%)

2.42

2.05

2.00

1.38

0.86